RESEARCHER PROFILE

Andrada Seicean

← Back to Iuliu Hațieganu University of Medicine and Pharmacy

A

Iuliu Hațieganu University of Medicine and Pharmacy

Pancreatic and Hepatic Oncology ResearchGallbladder and Bile Duct DisordersPancreatitis Pathology and TreatmentGastrointestinal Bleeding Diagnosis and TreatmentLiver Disease and Transplantation

Andrada Seicean works in Pancreatic and Hepatic Oncology Research, Gallbladder and Bile Duct Disorders, Pancreatitis Pathology and Treatment, Gastrointestinal Bleeding Diagnosis and Treatment, Liver Disease and Transplantation. Recorded institutional associations include Iuliu Hațieganu University of Medicine and Pharmacy, Institutul Regional de Gastroenterologie Prof. Dr. Octavian Fodor.

201Publications
3,144Citations
27H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

    2022 · 384 citations

  2. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline – March 2017

    2017 · 370 citations

  3. Quantitative contrast-enhanced harmonic EUS in differential diagnosis of focal pancreatic masses (with videos)

    2015 · 150 citations

  4. Curriculum for ERCP and endoscopic ultrasound training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

    2021 · 134 citations

  5. Risankizumab for Ulcerative Colitis

    2024 · 130 citations

  6. HELLP syndrome - a multisystemic disorder.

    2007 · 117 citations

  7. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

    2021 · 97 citations

  8. Endoscopic ultrasound-guided tissue sampling: European Society of Gastrointestinal Endoscopy (ESGE) Technical and Technology Review

    2025 · 83 citations

  9. IL-6 roles – Molecular pathway and clinical implication in pancreatic cancer – A systemic review

    2016 · 80 citations

  10. Quantitative Contrast-Enhanced Harmonic Endoscopic Ultrasonography for the Discrimination of Solid Pancreatic Masses

    2010 · 75 citations

  11. Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma

    2014 · 66 citations

  12. Mortality risk factors in chronic pancreatitis.

    2006 · 58 citations

  13. New targeted therapies in pancreatic cancer

    2015 · 50 citations

  14. Celiac plexus neurolysis in pancreatic cancer: The endoscopic ultrasound approach

    2014 · 50 citations

  15. Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non-Severe Disease

    2021 · 50 citations

  16. Harmonic Contrast-Enhanced Endoscopic Ultrasonography for the Guidance of Fine-Needle Aspiration in Solid Pancreatic Masses

    2015 · 49 citations

  17. Romanian Guidelines on the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency

    2015 · 42 citations

  18. Pain palliation by endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer.

    2013 · 42 citations

  19. Non-Invasive Assessment of Inflammation and Treatment Response in Patients with Crohn’s Disease and Ulcerative Colitis using Contrast-Enhanced Ultrasonography Quantification

    2015 · 41 citations

  20. Endoscopic ultrasound in chronic pancreatitis: Where are we now?

    2010 · 38 citations

  21. Contrast-enhanced harmonic versus standard endoscopic ultrasound-guided fine-needle aspiration in solid pancreatic lesions: a single-center prospective randomized trial

    2020 · 38 citations

  22. Endoscopic therapy in chronic pancreatitis: current perspectives

    2014 · 37 citations

  23. Maximizing the endosonography: The role of contrast harmonics, elastography and confocal endomicroscopy

    2017 · 32 citations

  24. Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma

    2021 · 29 citations

  25. International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG

    2026 · 28 citations

← Return to the university profile